Amlodipine Besylate
| 製品名 | Amlodipine Besylate |
|---|---|
| CAS番号 | 111470-99-6 |
| 同義語 | Amlodipine benzenesulfonate; Norvasc; Istin; Amlor; UK-4834011 |
| 分子式 | C20H25ClN2O5·C6H6O3S |
| 分子量 | 567.05 g/mol (free base: 408.88 g/mol) |
| 外観 | 白色からオフホワイトの結晶性粉末 |
| 分析(HPLC) | 98.0%–102.0% (on dried basis) |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.11 TP3T |
| 重金属 | 10 ppm以下 |
| 溶解度 | Slightly soluble in water; freely soluble in methanol, ethanol, and chloroform |
| パッケージ | 25 kg net in fiber drum with double polyethylene bags |
お困りですか? 弊社チームまでお問い合わせください

同義語: Amlodipine benzenesulfonate, Norvasc, Istin, Amlor, UK-4834011
Amlodipine Besylate is the besylate salt of amlodipine, a dihydropyridine calcium channel blocker. It is a white to off-white crystalline powder, practically insoluble in water but freely soluble in organic solvents such as methanol and chloroform. The compound is manufactured under cGMP conditions and is available in pharmacopeial grades (USP/EP/BP) suitable for oral solid dosage forms.
As a long-acting antihypertensive, amlodipine besylate is a cornerstone in the management of hypertension and angina. Its high protein binding and slow hepatic metabolism allow for once-daily dosing, making it a preferred choice for both monotherapy and fixed-dose combinations. The API is widely used in tablet formulations, often co-formulated with agents like valsartan, olmesartan, or atorvastatin to enhance therapeutic outcomes.
| パラメータ | 仕様 |
|---|---|
| 分析(HPLC) | 98.0%–102.0% |
| 識別 | IR, HPLC retention time |
| 乾燥減量 | ≤0.5% |
| 焼失残渣 | ≤0.11 TP3T |
| 重金属 | 10 ppm以下 |
| Organic Impurities | Meets USP/EP requirements |